SCHEMBL6284656

SCHEMBL6284656

CC(C)(C)NC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.60
NPC1 O15118 1/20 0.60
LMNA P02545 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
HSD17B10 Q99714 1/20 0.57
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
ALDH1A1 P00352 1/20 0.53
SCN4A P35499 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 2/20 0.49
SCN5A Q14524 1/20 0.47
SCN3A Q9NY46 1/20 0.47
USP30 Q70CQ3 1/20 0.47
KDM4E B2RXH2 2/20 0.47
UCHL1 P09936 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422735 1.00 SMN1; SMN2 (0.60) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL12057492 1.00 SMN1; SMN2 (0.60) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL8908114 0.92 SMN1; SMN2 (0.51) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL15307926 0.88 SMN1; SMN2 (0.60) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL2848716 0.88 SMN1; SMN2 (0.60) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL5403510 0.88 SMN1; SMN2 (0.60) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL27366305 0.87 SMN1; SMN2 (0.59) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL8237595 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL13114591 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1LMNANPSR1HSD17B10
SCHEMBL6466465 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1LMNANPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900238-B1 HIV protease inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2005-05-31 US disclosed
EP-0873519-A4 HIV PROTEASE INHIBITORS SCRIPPS RESEARCH INST (US) 2005-04-27 EP disclosed
EP-0873519-A1 HIV PROTEASE INHIBITORS The Scripps Research Institute (US) 1998-10-28 EP disclosed
WO-1997021100-A9 HIV PROTEASE INHIBITORS 1997-10-30 WO disclosed
WO-1997021100-A1 HIV PROTEASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 1997-06-12 WO disclosed
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
CN-1091432-A Can suppress the active peptide of hiv protease, its preparation with and medical use SANKYO CO (JP) 1994-08-31 CN disclosed
WO-1993013066-A1 CYCLIC AMIDES OF 3-AMINO-2-HYDROXY-CARBOXYLIC ACIDS AS HIV-PROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1993-07-08 WO disclosed